Brain Health
GLP-1 and PPARγ Drugs Show Direct Brain Insulin-Signaling Effects
Stanford researchers find pioglitazone and liraglutide improve CNS insulin signaling, measured via neuron-derived vesicles in blood.
Research Paper
Apr 20, 2026 0
Results for "SGLT2 Inhibitors" in Sleep & Mindfulness
20 articles
Brain Health
Liraglutide Shows Promise for Protecting Cognitive Function in Type 2 Diabetes
A Phase 3 trial investigates whether the GLP-1 drug liraglutide can slow cognitive decline in T2DM patients at elevated Alzheimer's risk.
Clinical Trial
May 20, 2026 0
Brain Health
GLP-1 Drugs May Treat Addiction and Depression Simultaneously
GLP-1 receptor agonists show early promise for co-occurring substance use and mood disorders by targeting shared brain reward pathways.
Review
Jun 28, 2026 0
Brain Health
Oral GLP-1 Drug Crosses Blood-Brain Barrier to Reverse Alzheimer's Metabolism
A new oral GLP-1 receptor agonist penetrates the brain, restoring astrocyte-neuron metabolic crosstalk disrupted in Alzheimer's disease.
Research Paper
Jun 23, 2026 0
Sleep & Recovery
GLP-1 Drugs Cut Stroke Risk by 25% and Death by 62% in Sleep Apnea Patients
A massive real-world study of 877,000 OSA patients finds GLP-1 receptor agonists dramatically reduce strokes, hospitalizations, and mortality.
Research Paper
Jun 27, 2026 0
Brain Health
GLP-1 Drugs Like Ozempic Linked to 62% Drop in Impulsivity-Driven Violence
A Rutgers study finds GLP-1 users show dramatically weaker links between impulsivity, alcohol use, and violent behavior.
Press Release
Jun 18, 2026 0
Sleep & Recovery
GLP-1 Drugs Are Being Rapidly Adopted by Sleep Apnea Patients
New research tracks the surging use of GLP-1 receptor agonists among adults with obstructive sleep apnea, raising questions about real-world impact.
Research Paper
May 27, 2026 0
Brain Health
NIH Discovers Why GLP-1 Weight Loss Drugs Plateau and How to Fix It
New NIH research reveals the brain-cell signaling mechanism behind GLP-1 drug plateaus and a potential way to extend their effects.
Press Release
May 26, 2026 0
Brain Health
Ozempic Cuts Depression and Anxiety Risk by Up to 44% in Landmark Study
A study of 100,000 people found semaglutide users had 44% lower depression risk and 42% fewer psychiatric hospitalizations.
Press Release
May 4, 2026 0
Brain Health
Ozempic Shows Unexpected Mental Health Benefits Beyond Weight Loss
New research reveals GLP-1 drugs like Ozempic significantly reduce depression, anxiety, and substance use disorders alongside weight management.
Press Release
Mar 28, 2026 2
Sleep & Recovery
GLP-1 Drugs May Reshape How We Treat Sleep Apnea and Obesity Together
New obesity medications are transforming OSA treatment, but key questions remain about optimal strategies for cardiometabolic risk reduction.
Research Paper
Apr 27, 2026 0
Sleep & Recovery
New Dopamine D3 Receptor Drug Candidate Shows Promise for Restless Legs Syndrome
A selective D3 receptor ligand reduces leg movement symptoms and improves sleep quality in a rat model of restless legs syndrome.
Research Paper
May 16, 2026 0
Brain Health
Breast Milk Sugar 2'-FL Boosts Memory and Learning Through Gut Bacteria
Study shows 2'-fucosyllactose improves cognitive function in mice by modulating gut microbiota and brain serotonin levels.
Research Paper
Apr 2, 2026 0
Brain Health
Dasatinib and Quercetin Reach the Brain in Early Alzheimer's Patients
A completed Phase 1/2 pilot trial tested whether the senolytic duo D+Q penetrates the brain in early Alzheimer's disease.
Clinical Trial
May 28, 2026 0
Brain Health
Diabetes Treatment May Mask Alzheimer's Biomarker Signals in Research
A new study warns that diabetes medications could confound Alzheimer's biomarker studies, distorting our understanding of the diabetes-dementia link.
Research Paper
May 13, 2026 0
Sleep & Recovery
Poor Sleep Quality Drives Blood Sugar Spikes and Instability in Type 2 Diabetes
New research reveals how sleep quality directly impacts glucose control, offering actionable insights for diabetes management.
Research Paper
Mar 28, 2026 0
Brain Health
Gadolinium Contrast Agent Gadobutrol Studied in Infants Under Age 2 for MRI Safety
A Phase 1 trial examines how gadobutrol moves through and exits the bodies of newborns and toddlers undergoing routine contrast MRI.
Clinical Trial
Jun 26, 2026 0
Sleep & Recovery
Gestational Diabetes Disrupts Sleep Patterns and Evening Chronotype in Pregnant Women
Study reveals how gestational diabetes significantly impairs sleep quality and shifts circadian rhythms toward evening preference.
Research Paper
Mar 29, 2026 1
Brain Health
Melatonin Blocks Toxic Protein Clumps That Drive Diabetes and Alzheimer's Disease
New research reveals how melatonin prevents harmful protein aggregation linked to both type 2 diabetes and brain degeneration.
Research Paper
Mar 28, 2026 1
Brain Health
New ALS Drug Tofersen Shows Promise in Long-Term Study for SOD1 Patients
Breakthrough antisense therapy demonstrates sustained benefits for rare genetic form of ALS in extended clinical trial.
Research Paper
Mar 29, 2026 1
Page 1 of 2Next